Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Spring Bank Pharmaceuticals stock

Own Spring Bank Pharmaceuticals stock in just a few minutes.

Spring Bank Pharmaceuticals, Inc is a biotechnology business based in the US. Spring Bank Pharmaceuticals shares (SBPH) are listed on the NASDAQ and all prices are listed in US Dollars. Spring Bank Pharmaceuticals employs 30 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Spring Bank Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SBPH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Spring Bank Pharmaceuticals share price

Use our graph to track the performance of SBPH stocks over time.

Spring Bank Pharmaceuticals shares at a glance

Information last updated 2021-01-22.
52-week range$0.80 - $2.50
50-day moving average $1.50
200-day moving average $1.48
Wall St. target price$1.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.78

Buy Spring Bank Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Spring Bank Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Spring Bank Pharmaceuticals financials

Gross profit TTM $-1,223,000
Return on assets TTM -33.74%
Return on equity TTM 0%
Profit margin 0%
Book value $4.24
Market capitalisation $5.2 million

TTM: trailing 12 months

Shorting Spring Bank Pharmaceuticals shares

There are currently 3,209 Spring Bank Pharmaceuticals shares held short by investors – that's known as Spring Bank Pharmaceuticals's "short interest". This figure is 91.8% down from 39,290 last month.

There are a few different ways that this level of interest in shorting Spring Bank Pharmaceuticals shares can be evaluated.

Spring Bank Pharmaceuticals's "short interest ratio" (SIR)

Spring Bank Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Spring Bank Pharmaceuticals shares currently shorted divided by the average quantity of Spring Bank Pharmaceuticals shares traded daily (recently around 40112.5). Spring Bank Pharmaceuticals's SIR currently stands at 0.08. In other words for every 100,000 Spring Bank Pharmaceuticals shares traded daily on the market, roughly 80 shares are currently held short.

However Spring Bank Pharmaceuticals's short interest can also be evaluated against the total number of Spring Bank Pharmaceuticals shares, or, against the total number of tradable Spring Bank Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Spring Bank Pharmaceuticals's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Spring Bank Pharmaceuticals shares in existence, roughly 0 shares are currently held short) or 0.0002% of the tradable shares (for every 100,000 tradable Spring Bank Pharmaceuticals shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Spring Bank Pharmaceuticals.

Find out more about how you can short Spring Bank Pharmaceuticals stock.

Spring Bank Pharmaceuticals share dividends

We're not expecting Spring Bank Pharmaceuticals to pay a dividend over the next 12 months.

Spring Bank Pharmaceuticals share price volatility

Over the last 12 months, Spring Bank Pharmaceuticals's shares have ranged in value from as little as $0.8 up to $2.5. A popular way to gauge a stock's volatility is its "beta".

SBPH.US volatility(beta: 1.12)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Spring Bank Pharmaceuticals's is 1.1186. This would suggest that Spring Bank Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Spring Bank Pharmaceuticals overview

As of November 20, 2020, Spring Bank Pharmaceuticals, Inc. was acquired by F-star Therapeutics Limited, in a reverse merger transaction. Spring Bank Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, discovers and develops therapeutics for the treatment of a range of cancers and inflammatory diseases using its proprietary small molecule nucleotide platform. The company is developing SB 11285, a next-generation immunotherapeutic cyclic dinucleotide for the treatment of selected cancers; novel STING antagonist compounds for the treatment of autoimmune and inflammatory diseases; and novel platform to enable the targeted delivery of payload molecules. It has a collaboration agreement with with Roche to explore the co-administration of SB 11285. The company was formerly known as Spring Bank Technologies, Inc.

Frequently asked questions

What percentage of Spring Bank Pharmaceuticals is owned by insiders or institutions?
Currently 7.891% of Spring Bank Pharmaceuticals shares are held by insiders and 28.16% by institutions.
How many people work for Spring Bank Pharmaceuticals?
Latest data suggests 30 work at Spring Bank Pharmaceuticals.
When does the fiscal year end for Spring Bank Pharmaceuticals?
Spring Bank Pharmaceuticals's fiscal year ends in December.
Where is Spring Bank Pharmaceuticals based?
Spring Bank Pharmaceuticals's address is: 35 Parkwood Drive, Hopkinton, MA, United States, 01748
What is Spring Bank Pharmaceuticals's ISIN number?
Spring Bank Pharmaceuticals's international securities identification number is: US8494311017
What is Spring Bank Pharmaceuticals's CUSIP number?
Spring Bank Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 849431101

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site